病原诱导的小麦ERF转录因子TaERF1b的原核表达及纯化

为了得到纯化的TaERFlb活性蛋白,将TaERFlb基因含有AP2／ERF结构域的片段插入原核表达载体pGEX-4T-1的多克隆位点中,构建GST-TaERFlb融合蛋白表达载体,并转化到犬肠杆菌BL21（DE3）中。0．1mmol／L1PTG即能诱导融合蛋白表达,37℃诱导4h或30℃诱导8h,融合蛋白均以包涵体的形式表达,16℃诱导12h,融合蛋白不表达。包涵体经溶解及稀释复性后,过GST亲和层析柱,获得纯化的融合蛋白,考马斯亮蓝法测得纯化蛋白的浓度约为0．5ug／ul,凝胶阻滞实验表明包涵体复性成功．所得蛋白具有生物活性：     

聚丙烯酰胺凝胶中蛋白质快速染色的改良法

聚丙烯酰胺凝胶中蛋白质的染色常采用考马斯亮蓝R250为染料进行染色,此法不仅操作繁琐、费时,而且由于需要脱色,很容易将一些染色较弱的蛋白区带颜色褪去,使之不能观察,灵敏度只能达到0.25μg。Reisner等人报道了以考马斯亮蓝G250为染料的快速简便染色方法,它能迅速地观察到凝胶中     

大肠杆菌表达的人IL-6复性条件研究

采用稀释法复性,筛选重组人白细胞介素-6(rhIL-6)包涵体蛋白的复性条件。结果显示,复性液的浓度、pH值、复性时间和复性蛋白浓度,对重组人白细胞介素-6复性效果有很大影响。在复性液为2mol/L尿素、pH8.5、复性时间为24h和复性蛋白浓度50μg/ml条件下,重组人白细胞介素-6包涵体蛋白的复性效果最佳。     

小菜蛾血淋巴蛋白质双向电泳技术体系的建立及优化

采用不同方法对小菜蛾Plutella xylostella(L.)血淋巴进行双向电泳研究,建立了一套适用于小菜蛾血淋巴蛋白质组分析的双向电泳体系。从样品处理方案、等电聚焦时间、染色方法等因素对小菜蛾双向电泳结果的影响进行了分析和优化。结果表明,TCA/丙酮沉淀法提取蛋白损失少,图谱均匀清晰,分辨率和重复性更高。不同长度胶条的最佳上样量不同,胶条长度为7、17、24cm时,最佳上样量依次为20～50μg、50～300μg、100～500μg,而聚焦时间则分别以24000、50000、65000vhr为宜。第二向聚丙烯酰胺凝胶的浓度以12%为宜,电泳后蛋白点呈均匀分布。银染的灵敏度明显高于考马斯亮蓝染色,可以检测出更多的蛋白点,但考马斯亮蓝染色在后续蛋白点质谱鉴定中具有优势。     

一种简便的考马斯亮蓝G250蛋白质染色方法

介绍一种快速、简便、几乎无背景的考马斯亮蓝G250(CBB G250)染色方法.该方法所用试剂仅为稀盐酸和CBB G250, CBB G250的工作浓度为0.0015%,灵敏度达0.02 μg/带, 染色2 h达70%,4 h以上或染色过夜即可充分染色.与以往的考马斯亮蓝染色方法相比,该方法有经济方便、灵敏度高、几乎无背景等优点,便于推广应用.     

重组人胰激肽原酶复性工艺的研究

目的:研究重组人胰激肽原酶包涵体变性及复性的工艺。方法:对本实验室构建的重组人胰激肽原酶大肠杆菌进行IPTG诱导表达表达成功后,菌体经超声破碎释放包涵体,包涵体经洗涤、变性、稀释和尿素梯度凝胶过滤色谱这两种方法复性后(Sephadex-G75),通过测定酶活检验复性效果。结果:①重组人胰激肽原酶工程菌经过IPTG诱导后能够表达目的蛋白,目的蛋白以包涵体形式存在,将细胞破碎后,包涵体经过3次洗涤,纯度达到71.93%;②变性包涵体经24小时稀释复性后,蛋白浓度达到72.61μg/m L,酶的比活达到13.84 U/mg;③变性包涵体经过2个小时的尿素梯度凝胶过滤复性后,蛋白浓度可达到830.07μg/mL,酶的比活达到48.61 U/mg。结论:两种复性方法均可以使包涵体达到一定的浓度和比活,比较发现尿素梯度凝胶过滤色谱具有复性时间短和比活力高等优点,可作为重组人胰激肽原酶复性的一种有效的手段。     

一种转移非特异性蛋白带的染色方法

考马斯亮蓝是常用的聚丙烯酰胺凝胶蛋白电泳的染料,利用硝酸纤维素膜(NCF)对染料的吸附作用,将低浓度的考马斯亮蓝(0.025%)染色液直接对NCF上的转移蛋白带进行染色,经实验反复验证.它是一种较好的NCF上转移非特异性蛋白带的染色方法.     

低毒高效的SDS-PAGE考马斯亮蓝染色方法比较

目的:比较SDS-PAGE的4种考马斯亮蓝染色方法。方法:以牛血清白蛋白为材料进行SDS-PAGE,分别比较考马斯亮蓝G-250(CBB G-250)盐酸法、CBB G-250-Al2(SO4)3法、Bio-Rad公司的Bio-Safe染色液及传统法等4种染色方法的灵敏度和操作性,并将上述4种染色方法应用于蛋白Markers检测。结果:CBB G-250-Al2(SO4)3法和Bio-Safe法的检测灵敏度都可达19.2 ng,而CBB G-250盐酸法和传统法的检测灵敏度则为28.9 ng。结论:CBB G-250盐酸法可作为快速、低毒、高效的染色方法,CBB-Al2(SO4)3法则可用于灵敏度要求较高的检测。     

桔小实蝇幼虫总蛋白双向电泳技术体系的建立和优化

【目的】建立和优化桔小实蝇幼虫Bactrocera dorsalis(Hendel)总蛋白的双向电泳条件。【方法】使用BPP法和3种TCA-丙酮法(TCA-丙酮-A法:直接加入裂解液磨样;TCA-丙酮-B法:样品提取液中加入40 mmol/L DTT;TCA-丙酮-C法:样品提取液中加入0.07%β-巯基乙醇)提取桔小实蝇幼虫总蛋白;使用13 cm和24 cm p H 4~7的IPG胶条分离桔小实蝇幼虫总蛋白;使用考马斯亮蓝法及硝酸银染色法对双向电泳凝胶进行染色;使用5800 MALDI-TOF-TOF MS/MS质谱分析仪对BPP法获得的特异蛋白进行质谱鉴定,并将检索数据库物种分别设为Metazoa(Animals)与Drosophila(Fruit flies)进行数据库检索。【结果】TCA-丙酮法中,TCA-丙酮-C法提取效果最好,BPP法优于所有TCA-丙酮法;使用考马斯亮蓝染色与硝酸银染色效果相当;使用24 cm胶条的蛋白分辨率明显高于13 cm胶条;检索数据库物种设为Metazoa(Animals)可获得比Drosophila(Fruit flies)更加全面的信息。【结论】使用24 cm p H 4~7的IPG胶条对BPP法提取的桔小实蝇幼虫总蛋白进行双向电泳,采用考马斯亮蓝法对双向电泳凝胶进行染色,可得到更好的双向电泳图谱,检索数据库时检索物种可优先设为Metazoa(Animals)。     

一种改进的双向电泳染色方法

本文涉及了双向电泳过程中的染色方法,即先用考马斯亮蓝染色,将胶上可见蛋白切下再银染的方法。这种方法可最大限度的减少胶中蛋白质点的损失,不仅避免了单一用考马斯亮蓝染色由于灵敏度不高而导致的低丰度蛋白的损失,也避免了单一用银染而使高丰度的蛋白因染色过度导致的损失。同时两种传统的染色方法结合完美,形成的新方法经济实用。     

人IL-18的基因克隆、表达及纯化

目的 :克隆人IL 1 8基因 ,并构建高表达人IL 1 8的工程菌 ,纯化获得重组人IL 1 8。方法 :从人肿瘤组织内提取总RNA ,利用逆转录聚合酶链反应扩增人IL 1 8基因 ,在基因的 5′和 3′端分别加上NcoI和EcoRI酶切位点 ,酶切后直接克隆至质粒表达载体pET2 8a( + )内 ,转化大肠杆菌BL2 1 (DE3) ,挑选转化子 ,IPTG诱导后SDS PAGE筛选高表达人IL 1 8的工程菌。提取表达菌质粒进行DNA序列分析。表达菌大量培养及IPTG诱导后 ,超声破菌收集包涵体 ,十二烷基肌苷酸钠溶解后用阳离子柱和分子筛纯化。结果 :克隆的人IL 1 8基因序列完全正确 ,工程菌表达的人IL 1 8约占菌体蛋白 30 % ,以包涵体形式存在 ,经阳离子柱和分子筛纯化获得了较纯的人IL 1 8。结论 :可用构建的工程菌大量制备人IL 1 8,为开展人IL 1 8药物的临床前研究奠定了基础。     

表达重组人骨形态发生蛋白-7工程菌的发酵及表达产物的纯化

目的:研究表达重组人骨形态发生蛋白-7工程菌的发酵和表达产物的纯化工艺。方法:利用16L发酵罐发酵培养工程菌,设定了溶氧、搅拌速度、诱导时机、补料和培养基pH值等发酵条件;通过包涵体洗涤、离子交换层析法纯化目的蛋白。结果:工程菌目的蛋白质表达量占菌体总蛋白质的30%以上,纯化后目的蛋白的纯度可达98%。结论:建立了大肠杆菌高效表达人骨形态发生蛋白-7的发酵及纯化工艺。     

Interplay of SOS induction,recombinant gene expression,and multimerization of plasmid vectors in Escherichia coli

Using pBR322- and pUC-derived plasmid vectors, a homologous (Escherichia coli native esterase) and three heterologous proteins (human interleukin-2, human interleukin-6, and Zymomonas levansucrase) were synthesized in E. coli IC2015(recA::lacZ) and GY4786 (sfiA::lacZ) strains. Via time-course measurement of beta-galactosidase activity in each recombinant culture, the SOS induction was estimated in detail and the results were systematically compared. In recombinant E. coli, the SOS response did not happen either with the recombinant insert-negative plasmid backbone alone or the expression vectors containing the homologous gene. Irrespective of gene expression level and toxic activity of synthesized foreign proteins, the SOS response was induced only when the heterologous genes were expressed using a particular plasmid vector, indicating strong dependence on the recombinant gene clone and the selection of a plasmid vector system. It is suggested that in recombinant E. coli the SOS response (i.e., activation of recA expression and initial sfiA expression) may be related neither to metabolic burden nor toxic cellular event(s) by synthesized heterologous protein, but may be provoked by foreign gene-specific interaction between a foreign gene and a plasmid vector. Unlike in E. coli XL1-blue(recA(-)) strains used, all expression vectors encoding each of the three heterologous proteins were multimerized in E. coli IC2015 strains in the course of cultivation, whereas the expression vectors containing the homologous gene never formed the plasmid multimers. The extent of multimerization was also dependent on a foreign gene insert in the expression vector. As a dominant effect of the SOS induction, recombinant plasmid vectors used for heterologous protein expression appear to significantly form various multimers in the recA(+) E. coli host.     

Production of a biologically active variant form of recombinant human secretin

A biologically active variant form of recombinant human secretin was produced using a gene fusion system designed to facilitate the purification of the protein. The fusion protein was recovered from the culture medium of Escherichia coli by IgG affinity chromatography, and recombinant secretin was released by cyanogen bromide treatment. A novel approach involving addition of a C-terminal Gly-Lys-Arg extension, was used to overcome the lack of amidation of recombinant proteins in Escherichia coli. The biological activity of the recombinant variant of secretin was at least 80% of the porcine secretin standard.     

人生存素survivin的克隆与分泌表达

旨在克隆人生存素( survivin)基因,并在原核系统中进行可溶性表达.采用RT-PCR方法从人乳腺癌细胞MCF-7中克隆survivin基因,将其重组到pAYZ表达栽体中,构建带有六聚组氨酸纯化标记的人survivin基因原核表达栽体pAYZ-survivin,将该载体转化大肠杆菌16C9进行表达.结果表明,成功克隆了survivin基因并构建了重组表达载体.融合蛋白主要以可溶性状态分泌到周质腔内存在.分离提取蛋白,HiTrap金属螯合柱进行亲和层析纯化,并经Western blot验证了高纯度survivin融合蛋白的表达.     

重组人蛋白激酶CK 2α亚基的原核表达、纯化与鉴定

将构建成功的人蛋白激酶 CK2 α亚基 c DNA的重组质粒 ,转化大肠杆菌 BL2 1 ( DE3) ,IPTG诱导后获特异高效表达 ,表达蛋白占菌体总蛋白的 30 % ,但大多数重组蛋白以不溶形式存在 .表达产物依次进行 DE- 5 2、P1 1磷酸纤维素和肝素 - Sepharose柱层析分离 ,最后从 30 9mg可溶性蛋白质中得到 6.1 mg纯化蛋白 . SDS- PAGE显示纯化的蛋白质为一分子量 4 2 k D的单一蛋白带 .Western- blot的结果证明 :纯化的表达产物与抗人 CK2α抗体可发生特异性免疫反应 . CK2α和β亚基等摩尔分子混合可组成有完全活性的全酶 .重组的 CK2全酶的性质和功能与该酶的已知特性一致 .这些结果证明重组蛋白是人蛋白激酶 CK2 α亚基     

Expression and purification of recombinant human histones

Nucleosomes reconstituted from bacterially expressed histones are useful for functional and structural analyses of histone variants, histone mutants, and histone post-translational modifications. In the present study, we developed a new method for the expression and purification of recombinant human histones. The human histone H2A, H2B, and H3 genes were expressed well in Escherichia coli cells, but the human histone H4 gene was poorly expressed. Therefore, we designed a new histone H4 gene with codons optimized for the E. coli expression system and constructed the H4 gene by chemically synthesized oligodeoxyribonucleotides. The recombinant human histones were expressed as hexahistidine-tagged proteins and were purified by one-step chromatography with nickel-nitrilotriacetic acid agarose in the presence of 6 M urea. The H2A/H2B dimer and the H3/H4 tetramer were refolded by dialysis against buffer without urea, and the hexahistidine-tags of the histones in the H2A/H2B dimer and the H3/H4 tetramer were removed by thrombin protease digestion. The H2A/H2B dimer and the H3/H4 tetramer obtained by this method were confirmed to be proficient in nucleosome formation by the salt dialysis method. The human CENP-A gene, the centromere-specific histone H3 variant, contains 28 minor codons for E. coli. A new CENP-A gene optimized for the E. coli expression system was also constructed, and we found that the purified recombinant CENP-A protein formed a nucleosome-like structure with histones H2A, H2B, and H4.     

Expression of murine interleukin-2 cDNA in E. coli and biological activities of recombinant murine interleukin-2

Murine interleukin-2 (MIL-2) cDNA was inserted into an expression vector carrying an Escherichia coli tryptophan promoter and was expressed in E. coli. Recombinant MIL-2 produced by E. coli supported the growth of murine CTLL-2 cells, but not that of human T-cell blasts. Recombinant MIL-2 strongly inhibited the binding of recombinant human IL-2 (HIL-2) to murine responder cells, but only very weakly inhibited the binding to human responder cells. Moreover, recombinant MIL-2 induced secondary alloantigen specific cytotoxic T lymphocytes (2 degrees CTL) from memory CTL and activated natural killer (NK) cells in murine systems in the same manner as recombinant HIL-2. The results suggest that the species hierarchy (that MIL-2 derived from native cell culture does not act on human T-cells) is due to the protein moiety, not the sugar moiety, and is to be ascribed to the difference in binding affinity of MIL-2 and HIL-2 to murine and human responder cells respectively, and that recombinant MIL-2 shares identical biological and immunological activities with recombinant HIL-2. Thus, MIL-2 might be a convenient tool for extensive studies of the pharmacological and physiological activities of IL-2 in murine models.     

Immobilization of mouse single-chain antibodies for affinity chromatography using the cellulose-binding protein

A laboratory method for obtaining immunoaffinity medium for chromatographic purification of recombinant human interferon alpha2b (IFN-alpha2b) is described. The method is based on oriented and non-covalent immobilization of recombinant antibody fragments on cellulose. The single-chain fragment variable (ScFv) against human IFN-alpha2b was genetically fused to cellulose-binding domain (CBD) from Clostridium thermocellum cellulosome and expressed in Escherichia coli. After the isolation of the target protein in functionally active form from bacteria cells its bioaffinity immobilization on several forms of cellulose powders has been carried out. The crystalline microgranular cellulose with immobilized ScFv-CBD-fusion protein was used as affinity medium to perform the purification of recombinant human IFN-alpha2b directly from clarified extract of E. coli cells.